Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02209259 · ClinicalTrials.gov registry record · NA
The Effect of Questionnaire Content on Measures of Pain Intensity, Magnitude of Disability, and Symptoms of Depression in Patients With Arm Illness
A NA study of Arm Illness, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
- 1
- Study location
NCT02209259: Completed NA study of Arm Illness, sponsored by Massachusetts General Hospital.
NCT02209259 is a NA study of Arm Illness that has completed, run by Massachusetts General Hospital. The registered enrollment target is 168 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02209259, a NA study of Arm Illness, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan a prospective randomized study to see whether negative questions affect measures of mood, pain, or disability. A total of 175 patients will participate at Massachusetts General Hospital.
Primary Outcome
A computerized assessment of upper extremity physical function measured at enrollment. The average T score of the U.S. population is 50, so the T score reported compares the study population to the U.S. population, where a T score greater than 50 is better than the average and a T score less than 50 is worse than the average.
Conditions Studied
Interventions
- OTHER PROMIS Upper Extremity Function
- OTHER Pain intensity
- OTHER PROMIS depression
- OTHER Positive affect negative affect scale (PANAS)
- OTHER standard PCS
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-02 |
| Phase | NA |
What the finished NCT02209259 record still lists
NCT02209259 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Arm Illness appearing as the primary indexed condition, and to 5 interventions - of which PROMIS Upper Extremity Function is the first listed.
NCT02209259 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02209259 about?
NCT02209259 is a clinical study titled "The Effect of Questionnaire Content on Measures of Pain Intensity, Magnitude of Disability, and Symptoms of Depression in Patients With Arm Illness". The investigators plan a prospective randomized study to see whether negative questions affect measures of mood, pain, or disability. A total of 175 patients will participate at Massachusetts General Hospital.
What is the current status of trial NCT02209259?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2014-05. Estimated completion is 2016-02.
What conditions does trial NCT02209259 study?
This clinical trial studies the following conditions: Arm Illness.
What interventions are being tested in trial NCT02209259?
The interventions under investigation include: PROMIS Upper Extremity Function (OTHER), Pain intensity (OTHER), PROMIS depression (OTHER), Positive affect negative affect scale (PANAS) (OTHER), standard PCS (OTHER).
Who is sponsoring clinical trial NCT02209259?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02209259 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02209259's enrollment target sits among peer trials
168 619th of 2000 higher than 1,379 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia